FDA Panel Pushing For Added Testing For Diabetes Drugs

July 3, 2008

An FDA panel is currently pushing for more extensive testing of diabetes drugs before they receive approval...Washington (ChattahBox) – An FDA panel is currently pushing for more extensive testing of diabetes drugs before they receive approval.

The FDA panel voted 14-2 on Wednesday in favor of the more extensive testing, which is aimed to improve safety standards of drugs.

The tougher testing is going to cost drug manufacturers more time and money, but the belief is that it will make the drugs much safe in the long run, cutting down the number of unforseen health risks in the long-term.

Diabetes experts, cardiologists, and others joined to make the recommendation for the change, to pick up on effects such as heart risks.

The FDA is not required to follow the advice of the panel, but typically does.

There are over 20 million people in the U.S. with Type 2 diabetes.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.